Breast Cancer

Experts highlight rising cancer rates in younger adults and the need for tailored support, treatment and survivorship care across the continuum.

So many friends I have met along the way wanted so badly to live and they weren't able to. They didn't lose and I didn't win. We all walked through something really hard and got different outcomes.

Nurse practitioner Bridget Hopkins discusses her metastatic breast cancer diagnosis, the role of clinical empathy and finding hope in stage 4 care.

Three lifelong friends, all breast cancer survivors, discuss the strength they found in supporting each other.

Dr. Wendy Woodward discussed the transformative rise of hypofractionated radiation.

Jonise S. Louis shares her journey of navigating a metastatic breast cancer diagnosis and chemotherapy while pregnant with the help of her oncology team.

Dr. Hope Rugo and advocate Jonise Louis discuss new ADCs, biomarker testing, and patient-centered dosing for metastatic triple-negative breast cancer.

Metastatic breast cancer survivor Casey Liening shares her adoption story in a candid interview.

Shondia McFadden-Sabari of Bold and Breastless shares how intuition and early detection saved her life during a dual breast cancer diagnosis.

Rosemary Carrera discusses her breast cancer journey, mastectomy and the personal decision to remove her implants at the Miami Breast Cancer Conference.

The FOURLIGHT-1 study found that atirmociclib plus Faslodex significantly improved progression-free survival in patients with HR+/HER2- metastatic breast cancer.

A phase 3 trial update for GLSI-100 shows a recurrence rate of less than 1% per year in patients with HER2-positive breast cancer after immunization.

Survivor Casey Liening discusses her metastatic breast cancer journey, reaching NED, and why a stage 4 diagnosis is a beginning, not a death sentence.

Dr. Don S. Dizon presented information on pregnancy with a breast cancer diagnosis and what patients should know.

A daughter’s cancer journey shows that survivorship is filled with constant waiting—from tests and treatment to life milestones — where each result can bring relief or fear.

Learn about male breast cancer, including common symptoms, diagnostic tests and how hormone therapy or surgery is used to treat this rare disease.

Dr. Anastasia Tousimis explores the feasibility, risks and surgical techniques for performing NSM in radiated patients to ensure oncologic safety.

That’s what I need to remember: Not made-up scenarios, but that if I’m open, truly open, to whatever life has in store, it will be OK.

A study of 922 patients shows the Aida test predicts 10-year recurrence risk and helps guide radiation decisions for invasive breast cancer.

A structured exercise program may reduce cognitive decline, often referred to as “chemo brain,” in patients receiving chemotherapy for the first time.

Preliminary INVINCIBLE-4 study data shows INT230-6 plus standard care may increase pathological complete response rates and improve patient safety.

During the Miami Breast Cancer Conference, CURE discussed ADCs with Dr. Kevin Kalinsky.

Dr. Kevin Kalinsky discusses common side effects associated with the FDA-approved combination of Enhertu and Perjeta for breast cancer.

The phase 3 persevERA study of giredestrant plus Ibrance missed its PFS goal, though positive data from other trials supports the drug.

Dr. Hope Rugo explains how antibody-drug conjugates like Datroway and Trodelvy are shifting the treatment landscape for patients with TNBC.